Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	893.32	-1036.25	104.32
Graham Fair Price	7.75	44.84	41.61
PEG	-21.43	0.87	-1.11
Price/Book	-5.31	0.85	0.90
Price/Cash Flow	-88.89	33.46	301.25
Prices/Earnings	-17.84	13.66	16.62
Price/Sales	-6.73	14.34	15.37
Price/FCF	-88.89	33.46	301.25
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.04	1.00	1.00
Operating Margin	54.29	0.36	0.23
ROA	15.22	< 0.005	< 0.005
ROE	0.01	0.02	15.25
ROIC	< 0.005	< 0.005	52.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.04	-25.67
Dividends QOQ	0.02	< 0.005	-89.43
EBIT QOQ	-0.15	0.57	283.61
EPS QOQ	-0.15	0.16	4.58
FCF QOQ	-0.91	7.55	730.77
Revenue QOQ	0.54	0.02	-96.50
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	701268.75	100.00
Days Sales Outstanding (DSO)	20.99	20.89	-0.49
Inventory Turnover	0.00	< 0.005	100.00
Debt/Capitalization	0.52	0.53	1.63
Quick Ratio	0.07	0.11	51.91
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	75.54	75.82	0.37
Cash	9.57	14.96	56.33
Capex	-0.05	-0.08	-54.98
Free Cash Flow	0.22	1.92	755.56
Revenue	4.41	4.49	1.90
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.04	0.09	114.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	37.84	-352.68	831.99
Naive Interpretation	Member

06 - Financial Health · Bad

Rating